Company Overview and News

16
Hurricane Florence, rising mortgage rates hurt U.S. homebuilding

13h reuters
WASHINGTON (Reuters) - U.S. homebuilding dropped more than expected in September as construction activity in the South fell by the most in nearly three years, likely held down by Hurricane Florence.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

30
Stocks come back from early losses as trading remains shaky

17h nzherald.co.nz
NEW YORK (AP) — U.S. stocks have mostly recovered from an early loss Wednesday as banks trade higher, canceling out losses for technology companies and retailers. Homebuilders are sinking after the Commerce Department said construction of new homes dropped in September, and retailers are also sharply lower.
HD FMCKI FMCKJ GM FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL NDAQ FMCC FMCCS FMCCT

16
Hurricane Florence, rising mortgage rates hurt US homebuilding

18h channelnewsasia
WASHINGTON: US homebuilding dropped more than expected in September as construction activity in the South fell by the most in nearly three years, likely held down by Hurricane Florence.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

16
U.S. housing starts, building permits fall in September

18h reuters
WASHINGTON (Reuters) - U.S. homebuilding dropped more than expected in September as construction activity in the South fell by the most in nearly three years, likely held down by Hurricane Florence.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

16
US housing starts sank 5.3 percent in September

18h nzherald.co.nz
WASHINGTON (AP) — U.S. home construction fell 5.3 percent in September, a sign that recent hurricanes and rising mortgage rates may be weighing on the market.
HD FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

30
Stocks head lower, giving back some of a big rally

18h nzherald.co.nz
NEW YORK (AP) — U.S. stocks are falling Wednesday after their biggest gain in more than six months. Homebuilders are sinking after the Commerce Department said construction of new homes dropped in September, and retailers are also sharply lower. IBM tumbled after it announced disappointing quarterly revenue. Netflix jumped after it announced big subscriber gains, which relieved investors after the stock had slumped over the summer.
HD FMCKI FMCKJ GM FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL NDAQ FMCC FMCCS FMCCT

16
US housing starts fall more than expected in September

18h channelnewsasia
U.S. homebuilding dropped more than expected in September as construction activity in the South fell by the most in nearly three years, likely held down by Hurricane Florence.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

16
Struggling with Housing Costs, Renters Continue to Find Affordability in Renting

18h globenewswire
MCLEAN, Va., Oct. 17, 2018 (GLOBE NEWSWIRE) -- New research released today by Freddie Mac Multifamily finds a large and growing segment of renters continue to believe renting is a more affordable option than owning, even as many of those same renters are feeling the squeeze of rising housing costs. The latest “Profile of Today’s Renter” reveals that all generations of renters continue to perceive renting as the more affordable housing choice and remain satisfied with their current situation.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

17
Nomura to pay $480 million to U.S. over 'fraudulent' mortgage-backed securities

2018-10-16 reuters
NEW YORK (Reuters) - Nomura Holdings Inc has agreed to pay $480 million to resolve civil claims by the U.S. government that it misled investors in marketing residential mortgage-backed securities, U.S. authorities said on Tuesday.
NMR FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ 8604 FMCC N33 NRSCF FMCCS FMCCT

17
Nomura to pay US$480 million to US over 'fraudulent' mortgage-backed securities

2018-10-16 channelnewsasia
Nomura Holdings Inc has agreed to pay US$480 million to resolve civil claims by the U.S. government that it misled investors in marketing residential mortgage-backed securities, U.S. authorities said on Tuesday.
NMR FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ 8604 FMCC N33 NRSCF FMCCS FMCCT

16
Mortgage Translations Clearinghouse Launched to Help Borrowers with English Language Barriers

2018-10-15 globenewswire
WASHINGTON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- The Federal Housing Finance Agency (FHFA), Freddie Mac (OTCQB:FMCC), and Fannie Mae (FNMA/OTC) together announce the launch of Mortgage Translations – a centralized clearinghouse of online resources to assist lenders, servicers, housing counselors, and other real estate professionals in serving limited English proficient (LEP) borrowers.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

16
Se lanza el Centro de Traducciones Hipotecarias como ayuda para los prestatarios con barreras en usar el inglés

2018-10-15 globenewswire
WASHINGTON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- La Agencia Federal de Financiamiento para la Vivienda (FHFA, siglas en inglés), Freddie Mac (OTCQB:FMCC), y Fannie Mae (FNMA/OTC) anuncian en conjunto el lanzamiento de Traducciones Hipotecarias – un centro de información centralizado con recursos en línea para ayudar a prestadores, administradores, asesores en asuntos de vivienda y otros profesionales de bienes raíces a ofrecer servicios a prestatarios con dominio limitado del inglés (LEP, siglas en inglés).
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FNMA FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

16
Freddie Mac Prices $646 Million Multifamily K-Deal, K-L03

2018-10-15 globenewswire
MCLEAN, Va., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are multifamily mortgage-backed securities.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

16
Freddie Mac Announces First Fully Integrated, Self-Employed Borrower Income Assessment Solution; Automation and Creativity Give Lenders the Freddie Edge℠

2018-10-15 globenewswire
MCLEAN, Va., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) Freddie Mac announced today that Loan Product Advisor® – its automated underwriting system (AUS) – now offers the first and only AUS-integrated self-employment income assessment solution available for the mortgage industry. “Our clients demanded full integration, and Freddie Mac delivered,” said Dave Lowman, Executive Vice President, Single-Family, Freddie Mac.
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC FMCCS FMCCT

21
Weekly Commentary: Rude Awakening Coming

2018-10-14 seekingalpha
There's little satisfaction writing the CBB after a big down week in the markets. Motivation seems easier to come by after up weeks, perhaps my defiant streak kicking in. I find myself especially melancholy at the end of this week. There's a rude awakening coming - perhaps it's finally starting to unfold.
DGLD BATS 4162 CS FMCKI FMCKJ UGLD SCGLF UBS FMCCO FMCCP DSLV FMCCM VIIX FMCCN CSSLF VIIZ FMCCI FMCCJ SCGLY FMCCG FMCKO NYTAB FMCKP FMCKM FMCKN FMCKK FMCKL CSGKF NDAQ T FMCC 2007 ZIV USLV GLE TVIX FMCCS ULSGF FMCCT XIV

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 313400657